{
    "Trade/Device Name(s)": [
        "DYNEX SmartPLEX MMRV IgG Assay Kit"
    ],
    "Submitter Information": "DYNEX Technologies, Inc.",
    "510(k) Number": "K212769",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091616"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OPL"
    ],
    "Summary Letter Date": "December 7, 2022",
    "Summary Letter Received Date": "December 7, 2022",
    "Submission Date": "June 12, 2023",
    "Regulation Number(s)": [
        "21 CFR 866.3510"
    ],
    "Regulation Name(s)": [
        "Rubella virus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology",
        "serology"
    ],
    "Analyte(s)": [
        "Measles IgG",
        "Mumps IgG",
        "Rubella IgG",
        "Varicella-Zoster Virus (VZV) IgG"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "DYNEX Multiplier Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex immunoassay",
        "Chemiluminescence"
    ],
    "Methodologies": [
        "ELISA-like multiplex assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Multiplex"
    ],
    "Document Summary": "FDA 510(k) summary for DYNEX SmartPLEX MMRV IgG multiplex immunoassay detecting IgG antibodies to Measles, Mumps, Rubella, and VZV in serum using DYNEX Multiplier Analyzer",
    "Indications for Use Summary": "Qualitative detection of IgG antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Virus in human serum from adults and pediatric patients older than 1 year, as an aid in determining serological status; not intended for donor screening or point-of-care use",
    "fda_folder": "Microbiology"
}